Literature DB >> 19950174

A role for IL-18 in protective immunity against Mycobacterium tuberculosis.

Bianca E Schneider1, Daniel Korbel, Kristine Hagens, Markus Koch, Bärbel Raupach, Jana Enders, Stefan H E Kaufmann, Hans-Willi Mittrücker, Ulrich E Schaible.   

Abstract

Tuberculosis remains the most hazardous bacterial infection worldwide. The causative agent, Mycobacterium tuberculosis, is a facultative intracellular pathogen of resting MPhi. IFN-gamma secreted by natural killer, CD4 Th 1 and CD8 T cells upon instruction by IL-12 and -18 activates MPhi to restrict mycobacterial growth. Production of both cytokines is induced by TLR signalling in DC and MPhi. Mice deficient for the TLR adaptor, MyD88, are highly susceptible to M. tuberculosis infection. Shared usage of MyD88 by signalling cascades for TLR and receptors for IL-1 and IL-18 prompted us to revisit the role of IL-18 during experimental infection with M. tuberculosis. We show that mice deficient for IL-18 and MyD88 but not for IL-18 receptor promptly succumbed to M. tuberculosis infection in contrast to WT or TLR-2/-4 double KO mice indicating that lack of IL-18 contributes to the high susceptibility of MyD88 KO mice to M. tuberculosis. Without IL-18, the protective Th1 response was decreased and hence, mycobacterial propagation was favoured. Neutrophil-driven lung immunopathology concomitant with unrestrained growth of tubercle bacilli are most likely responsible for the premature death of IL-18 KO mice. Thus, IL-18 plays a decisive role in protective immunity against tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19950174      PMCID: PMC3189623          DOI: 10.1002/eji.200939583

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  46 in total

1.  IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway.

Authors:  Joseph R Maxwell; Rajwardhan Yadav; Robert J Rossi; Carl E Ruby; Andrew D Weinberg; Hector L Aguila; Anthony T Vella
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

Review 2.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.

Authors:  Luke A J O'Neill; Andrew G Bowie
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

Review 3.  Innate immunity in tuberculosis: myths and truth.

Authors:  Daniel S Korbel; Bianca E Schneider; Ulrich E Schaible
Journal:  Microbes Infect       Date:  2008-08-13       Impact factor: 2.700

4.  Rapid neutrophil response controls fast-replicating intracellular bacteria but not slow-replicating Mycobacterium tuberculosis.

Authors:  P Seiler; P Aichele; B Raupach; B Odermatt; U Steinhoff; S H Kaufmann
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

5.  NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis.

Authors:  Carl G Feng; Mallika Kaviratne; Antonio Gigliotti Rothfuchs; Allen Cheever; Sara Hieny; Howard A Young; Thomas A Wynn; Alan Sher
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

6.  Caspase-1-mediated activation of interleukin-1beta (IL-1beta) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection.

Authors:  Bärbel Raupach; Soo-Kyung Peuschel; Denise M Monack; Arturo Zychlinsky
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

7.  IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection.

Authors:  Cecile M Fremond; Dieudonnée Togbe; Emilie Doz; Stephanie Rose; Virginie Vasseur; Isabelle Maillet; Muazzam Jacobs; Bernhard Ryffel; Valerie F J Quesniaux
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

8.  Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis.

Authors:  Hans-Willi Mittrücker; Ulrich Steinhoff; Anne Köhler; Marion Krause; Doris Lazar; Peggy Mex; Delia Miekley; Stefan H E Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

9.  Red blood cell arginase suppresses Jurkat (T cell) proliferation by depleting arginine.

Authors:  Andrew Bernard; Michael Kasten; Cindy Meier; Erin Manning; Stephanie Freeman; Will Adams; Phillip Chang; Bernard Boulanger; Paul Kearney
Journal:  Surgery       Date:  2007-12-21       Impact factor: 3.982

10.  Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9.

Authors:  Christoph Hölscher; Norbert Reiling; Ulrich E Schaible; Alexandra Hölscher; Clara Bathmann; Daniel Korbel; Insa Lenz; Tanja Sonntag; Svenja Kröger; Shizuo Akira; Horst Mossmann; Carsten J Kirschning; Hermann Wagner; Marina Freudenberg; Stefan Ehlers
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

View more
  41 in total

1.  Coexistent Malnutrition Is Associated with Perturbations in Systemic and Antigen-Specific Cytokine Responses in Latent Tuberculosis Infection.

Authors:  Rajamanickam Anuradha; Saravanan Munisankar; Yukthi Bhootra; Nathalla Pavan Kumar; Chandrakumar Dolla; Paul Kumaran; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

2.  IL-18 genetic polymorphisms may contribute to the pathogenesis of tuberculosis among Asians: a meta-analysis of case-control studies.

Authors:  Xiao-Ling Yu; Fei Zhao; Jun Zhang; Xiao-Ming Pan
Journal:  Mol Biol Rep       Date:  2014-06-27       Impact factor: 2.316

3.  IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease.

Authors:  Xiyuan Bai; Alida R Ovrutsky; Marinka Kartalija; Kathryn Chmura; Amanda Kamali; Jennifer R Honda; Rebecca E Oberley-Deegan; Charles A Dinarello; James D Crapo; Ling-Yi Chang; Edward D Chan
Journal:  Int Immunol       Date:  2011-10-27       Impact factor: 4.823

4.  Diminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infection.

Authors:  Nathella Pavan Kumar; Parakkal Jovvian George; Paul Kumaran; Chandra Kumar Dolla; Thomas B Nutman; Subash Babu
Journal:  J Infect Dis       Date:  2014-06-06       Impact factor: 5.226

5.  Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo.

Authors:  Katrin D Mayer-Barber; Daniel L Barber; Kevin Shenderov; Sandra D White; Mark S Wilson; Allen Cheever; David Kugler; Sara Hieny; Patricia Caspar; Gabriel Núñez; Dirk Schlueter; Richard A Flavell; Fayyaz S Sutterwala; Alan Sher
Journal:  J Immunol       Date:  2010-03-03       Impact factor: 5.422

Review 6.  Cytokines and Chemokines in Mycobacterium tuberculosis Infection.

Authors:  Racquel Domingo-Gonzalez; Oliver Prince; Andrea Cooper; Shabaana A Khader
Journal:  Microbiol Spectr       Date:  2016-10

Review 7.  Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis.

Authors:  Irini Sereti; Alison J Rodger; Martyn A French
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

8.  Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines.

Authors:  Nathella Pavan Kumar; Rathinam Sridhar; Vaithilingam V Banurekha; Mohideen S Jawahar; Michael P Fay; Thomas B Nutman; Subash Babu
Journal:  Ann Am Thorac Soc       Date:  2013-10

9.  ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo.

Authors:  Andreas Kupz; Ulrike Zedler; Manuela Stäber; Carolina Perdomo; Anca Dorhoi; Roland Brosch; Stefan H E Kaufmann
Journal:  J Clin Invest       Date:  2016-04-25       Impact factor: 14.808

Review 10.  Cytokines in the balance of protection and pathology during mycobacterial infections.

Authors:  Egídio Torrado; Andrea M Cooper
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.